Article
Chemopreventive drug treatment in subjects with genetic predisposition to cancer: prescriber liability and healthcare disparities.
Pharmacogenomics - 1 Apr 2004
Palmer Larry I, Martin Robert C G, Hein David W
Abstract excerpt
Advancements in pharmacogenomics and chemoprevention promise to reduce cancer incidence and mortality, but utilization will undoubtedly be accompanied with ethical and legal issues that largely remain unexplored or discussed. As pharmacogenomic information is assessed more comprehensively and inexpensively, it will influence decisions regarding when and to whom chemoprevention therapy will be initiated....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.